Network’s Approach to Adapting Knowledge Translation Strategies for Neuromuscular Diseases: Knowledge Translation Canada Scientific Meeting

The network is excited to share that on behalf of the NMD4C Knowledge Translation team, Drs. Cynthia Gagnon and Homira Osman have had a poster presentation accepted for inclusion at the Knowledge Translation Canada (KT Canada) 2022 Virtual Scientific Meeting.

The poster presentation “A Network’s Approach to Adapting Knowledge Translation Strategies for Neuromuscular Diseases” focuses on the barriers and facilitators to knowledge translation (KT) for neuromuscular diseases, describing how some of these were amplified during the pandemic, and providing examples of effective KT activities that have improved access and uptake of information which raise standards of care and research, with particular focus on the application of the knowledge-to-action framework to address the needs and challenges of Spinal muscular atrophy (SMA).

Alongside the specific example of the knowledge-to-action framework in SMA, the key messages from the poster include:

Collaboration between clinicians, academics, researchers, patient partners is critical for planning, delivering, and implementing KT activities that intend to influence clinical and policy change.

A pan-Canadian network can fulfil an important role of knowledge broker and can help to address the limited, fragmented, and emerging evidence and clinical expertise.

The use of multi-faceted strategies for knowledge dissemination is important: webinars, social media, newsletters are effective ways to maximize engagement, reach and uptake of knowledge.

The full poster will be available on the KT Canada website after the event, so check back to see the full content!

KT Canada’s Virtual Scientific Meeting 2022

The KT Canada Virtual Scientific Meeting is held entirely online, running from May 4th to May 6th, 2022, with the theme “Developing and evaluating tailored dissemination strategies for different audiences: What have we learned from dissemination science during COVID-19?”. The presentations include 15-minute live oral presentations, and pre-recorded poster presentations. The full agenda is available on the KT Canada Scientific Meeting website; if you are interested in attending this virtual event, you can register online.

The goals of KT Canada are to improve how research results are communicated, develop a consensus on KT terminology and methods for measuring success, evaluate various KT approaches and to find ways to ensure that KT efforts have a lasting impact across the continuum of care by engaging health professionals, community members and various health decision-making groups.

NMD4C Knowledge Translation Strategy

The NMD4C KT strategy focuses on the development, dissemination, and implementation of KT products (including clinical care guidelines) tailored to various audiences with the objectives in pursuit of raising the standard of care for NMD and improving access to NMD therapies across Canada. More information about the NMD4C KT working group is available on the KT page of our website.

 

Knowledge Translation Canada logo

Read next...

AGAMREE (vamorolone) Approved treatment for DMD in Canada

A Milestone in Neuromuscular Care: AGAMREE® (vamorolone) Approved as the First Treatment for Duchenne Muscular Dystrophy in Canada

Health Canada has approved AGAMREE® (vamorolone), the first-ever treatment for Duchenne Muscular Dystrophy (DMD) in Canada. Patient Support Program opens for enrollment on October 10, 2025.

Website - SBMA published on CMAJ.png

New Best Practice Recommendations for SBMA Care in Canada

Congratulations to Dr. Kerri Schellenberg, the team of Canadian experts, NMD4C Steering Committee members and Investigators, on publishing the first Canadian SBMA care guidelines!

2025 NMD4C ANNUAL MEETING

Advancing Neuromuscular Research and Care: Highlights from the 2025 NMD4C Annual Meeting

On September 11, NMD4C hosted its 2025 Annual Meeting in Ottawa, bringing together clinicians, researchers, trainees, and partners for a full day of collaboration, strategic dialogue, and community-building.

2025 Clinical Summer School

NMD4C Hosts Inaugural Clinical Summer School to Empower Canada’s Future Neuromuscular Leaders

On September 10–11, NMD4C hosted its inaugural Clinical Summer School in Ottawa, bringing together 19 neuromuscular clinical fellows from across Canada for two days of hands-on training, mentorship, and networking. Led by national experts and co-chaired by Drs. Gordon Jewitt and Marianne Nury, the program complemented NMD4C’s accredited lecture series and fostered peer connection through dedicated community-building sessions.

2026 Neuromuscular Postdoc Research Fellowship Competition

2026 Neuromuscular Postdoctoral Research Fellowships Funding Competition is Now Open!

Apply Or Share this opportunity with the trainees in your network — Deadline: October 14, 2025. Hosted by Neuromuscular Disease Network for Canada (NMD4C) and Muscular Dystrophy Canada (MDC)

Clinical Fellowship Awardees

Announcing the 2026 Neuromuscular Clinical Fellowship Award Recipients

We are excited to share that the 2026 Neuromuscular Clinical Fellowship Awards have been awarded! These fellowships strengthen clinical training in neuromuscular medicine and help prepare the next generation of specialists who will advance neuromuscular care across Canada.